Trial
NCT00527410
A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Leptomeningeal Carcinomatosis
Intervention
RTA 744
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-30